FDA Approved: DEXTENZA — Original Application (Ocular Therapeutix, Inc.)

View source ↗

Summary

FDA approves DEXTENZA (dexamethasone) ophthalmic insert by Ocular Therapeutix for postoperative ocular inflammation and pain following ophthalmic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ophthalmic Postoperative Inflammation
• Ophthalmic Postoperative Pain

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

ORIG AP for DEXTENZA (DEXAMETHASONE)